H&H working with FDA to up U.S. baby formula supplies

Health and Happiness (H&H) International Holdings

04/06/2022 15:44

By Richa Naidu
    LONDON, June 4 (Reuters) - Health and Happiness (H&H)
International Holdings Ltd  1112.HK  is working closely with the
U.S. Food and Drug Administration (FDA) to gain approval to send
more infant formula supplies to the United States, a top
executive said.
    Top manufacturer Abbott Laboratories  ABT.N  in February
recalled dozens of types of its Similac, Alimentum and EleCare
formulas, creating one of the most urgent baby food shortages in
recent history for U.S. families.
    H&H, China's fourth-biggest and the world's tenth-largest
infant formula supplier, has joined European rivals in stepping
up shipments to address the shortage, according to Chief
Strategy & Operations Officer Akash Bedi.
    The maker of infant formula Biostime is "urgently working to
provide assistance and is in the process of shipping infant
formula from France and Australia to the U.S. to respond to the
crisis," Bedi said in an emailed statement.
    "H&H is working closely with the FDA and other government
bodies to gain approval and hope to be able to send products in
the coming weeks," he added.
    The company has not seen any impact from the U.S. shortage
in the Chinese market, Bedi added.

 (Reporting by Richa Naidu; Editing by Matt Scuffham and
Christina Fincher)
 ((richa.naidu@tr.com ; Follow me on Twitter https://twitter.com/Richa_Writes;
 +44 755 755 9587;))